ALBERTDAVDNSEAlbert David LimitedHighNeutral
Announced Tue, 12 May · 19:20 IST

Albert David Limited has informed the Exchange regarding Outcome of Board Meeting held on May 12, 2026.

Ceo ResignedCeo Appointed ExternalKmp ResignedManagement Changes View source PDF

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-10.5%1-day move
₹790.00
prior close
₹730.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.9-2.3-2.1-10.5-8.6-10.1-9.2-10.4-10.6-8.8-8.3-11.2
Up moveDown movePending
AI summary

Albert David Limited's board meeting on May 12, 2026 resulted in several key outcomes. The board appointed Mr. Amit Mahla as the new CEO effective immediately, filling the vacancy created when Mr. Umesh Manohar Kunte resigned as Managing Director & CEO from December 18, 2025. The company also approved audited financial results for FY2026, showing a significant decline with net profit of Rs. -149.47 Lacs compared to Rs. 1,720.08 Lacs in FY2025, despite total income of Rs. 34,105.14 Lacs. The board recommended a final dividend of Rs. 5 per share (50%) for FY2026, subject to shareholder approval at the 87th AGM scheduled for August 6, 2026. Additionally, PwC was reappointed as internal auditors and S. Gupta & Co. as cost auditors for FY2026-27. The statutory auditors issued an unmodified opinion on the financial statements.

Likely market impact

The appointment of a new CEO with extensive pharmaceutical industry experience (28+ years across Cipla, Sun Pharma, JB Pharma) may provide stability following the prior CEO's departure. However, shareholders should note the significant decline in profitability for FY2026, though the dividend recommendation provides some return to investors.